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Biosensors are devices that recognize, analyze, and transduce signal for 
detection via biological materials with bio-recognition properties.  As of now, almost 
all kinds of biomaterials, including microbial cells, organelles, proteins, and nucleic 
acid, have been used for biosensors. In this dissertation, two kinds of biomaterials, 
enzymes and organelles, have been used for novel biosensor development. The 
primary focus of the research is the inhibition mechanism of laccase and 
mitochondria by different environmental toxins, like arsenic and pesticides. 
In Chapter 2, a laccase-based biosensor was developed for arsenic sensing. 
Inhibition of oxygen reduction by arsenic was observed electrochemically via 
laccase immobilized with anthracene-modified multiwalled carbon nanotubes on a 
Toray carbon paper electrode. First, it was found that laccase is inhibited by 
arsenite and arsenate, and the inhibition mechanism was further determined as 
mixed inhibition (with preference to an uncompetitive inhibition model). Second, 
the laccase-modified electrodes were then fabricated into a self-powered 
biosensor with flavin-adenine-dinucleotide-dependent glucose dehydrogenase-
based bioanodes. The biosensor was operated at 10% of its maximum current and 
demonstrated a detection limit of 13 µM for arsenite and 132 µM for arsenate. 
In Chapter 3, a mitochondrial paper-based biosensor was fabricated. 
 iv 
 
Coupled mitochondria were isolated from bovine heart and demonstrated an 
amperometrical detection limit of 20 nM for malathion, a common pesticide. The 
inhibition mechanism by malathion to mitochondrial metabolism was studied 
electrochemically and was determined to be uncoupling rather than inhibition.  
In Chapter 4, the inhibition mechanism of mitochondria by rotenone, 
carboxin, and antimycin was studied. It was also discovered that the synergy 
between riboflavin derivatives and ubiquinone can be altered by using different 
solvents during the electrode fabrication process. A further study indicated that 
lipid membrane is capable of altering the reaction dominance between ubiquinone 
and riboflavin derivatives. Finally, it was discovered that mitochondria release 
riboflavin derivatives under inhibition and it is believed that this alteration of the 
micro-environment was the cause of the change in mitochondrial electrochemistry 
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1.1. Overview of biosensor 
A biosensor is a device that utilizes biological material for the quantitative 
detection of a specific analyte. The components of a biosensor usually include a 
biorecognition component and a transducing component.1 Nowadays, biosensors 
utilize a very broad choice of materials for both components. For both the 
biorecognition component and the transducer, almost all of the available 
biomaterials, such as microbial cells, organelles, proteins, and nucleic acid, have 
been investigated. After only 60 years of development, both spectroscopic 2-7  and 
electrochemical biosensors8-12 have been extensively researched and reported. A 
schematic of the biosensing process is shown in Figure 1.1.  
The first biosensor was constructed back in the 1960s,1,13 which was aimed 
at detecting glucose. The development of first-generation biosensors began by 
utilizing glucose oxidase to oxidize glucose and detect the H2O2 generated by the 
enzyme as a coupled side reaction. In this application, glucose oxidase oxidizes 
glucose to gluconolactone and reduces oxygen to H2O2. The concentration of 
glucose is analyzed by oxidizing the H2O2 generated by glucose oxidase with an 





is still being extensively studied for the broad involvement of H2O2 in biological 
systems, since H2O2 is the product of O2 reduction by many different kinds of 
enzyme in biological systems, and is therefore used for detection of glucose,14-16 
lactate,17-19 lactose,20-21 etc. However, these first-generation biosensors face a few 
technical problems such as dependency on oxygen and poor selectivity. Because 
of the oxygen dependence and the low solubility of oxygen in aqueous solutions, 
the sensitivity of these biosensors is limited. Additionally, many other common 
biological species, such as uric acid and acetaminophen,22 are electrochemically 
active at the oxidation potential of H2O2, which limits selectivity. In order to 
overcome these problems, especially to increase the specificity of the biosensor 
and eliminate oxygen dependence, the second generation of biosensors were 
developed.  
The second-generation biosensors utilize artificial mediators as electron 
acceptors instead of oxygen. These redox mediators are mostly organometallic 
redox active species that are reduced by the enzyme when the substrate is 
oxidized, or vice versa. The benefit of utilizing redox mediators is that the solubility 
of redox mediators is usually significantly greater than O2, thus removing the kinetic 
limit caused by the concentration of O2 and obtaining a much higher signal from 
the biosensors. Meanwhile, the large number of different redox mediators allows 
a broad choice of operating potential of biosensors, therefore avoiding the 
interference that H2O2 detection often encounters in a biological system. The 
choice of redox mediator is abundant for biosensors. A few commonly used redox 





mediators utilized for second-generation biosensors were solution-based, which 
made their fabrication process easy but limited the application potential of these 
biosensors severely due to the significant amount of mediator required, as well as 
limited current caused by transport limitations and degradation of mediator. 
Therefore, attempts to immobilize mediators at the electrode surface have also 
been performed. The most commonly used immobilization methods for redox 
mediators are tethering redox active molecules into a polymer backbone32-34 or 
using pyrene π-π stacking systems.35-38 
The third generation of biosensors, in the perspective of electrochemical 
biosensors, uses direct electron transfer (DET). One example of direct electron 
transfer is oxygen reduction of laccase where an anthracene-modified carbon 
nanotube is used to dock the T1 copper center towards the electrode and utilize 
the small distance (0.65 nm) for the electrons to tunnel between the enzyme and 
carbon.39 However, for microbial cells, DET is more controversial since most of the 
DET reported for microbial cells involve electron transfer with an electrochemically 
active species produced by the microbial cells. 
 
1.2. Electrochemical biosensor 
Cost efficiency is the key factor to make electrochemical biosensors stand 
out in terms of market potential. Applications of electrochemical biosensors include 
implantable medical devices, field-deployable water monitoring devices, food 
quality monitoring, etc. The first biosensor utilized glucose oxidase,1 an enzyme 





were studied. Microbial materials were introduced to overcome a few drawbacks 
of using enzymes, such as short lifespans, long and costly purification processes, 
and the need to provide cofactors/coenzymes for the generation of measurable 
product, etc.40 In most cases, microbial cells contain a large variety of enzymes 
that allows detection of a broad range of analytes, and they can be directly applied 
on the electrode without purification. However, the membrane structure of 
microbial cells limits the response time of microbial biosensors. To overcome that, 
organelle biosensors come into play. The goal for organelle biosensors is to merge 
the advantages of enzymatic and microbial biosensors to obtain a fast response 
while maintaining a relatively easy purification process. The diversity of biosensor 
materials has increased dramatically recently and novel materials such as DNA 
and tissue have been studied as well. While these novel materials are seen more 
and more commonly in recent publications, the primary categories of biosensor 
materials can be classified as enzymatic, microbial, organelle, and nucleic acid. 
 
1.2.1 Enzymatic biosensors 
Enzymes are a type of protein that catalyzes a specific category of chemical 
reactions. Enzymatic biosensors are by far the most studied biosensor and have 
the most widely used application. Enzymatic biosensors possess advantages such 
as outstanding specificity, rapid sensor response, and easy fabrication. Enzymatic 
biosensors can be classified into two categories: utilizing the analyte as the 
substrate, and using enzyme inhibition to detect an inhibitor. Now a vast variety of 





substrates (such as glucose,41-43 pyruvate,44-46 lactate,47-49 etc.), which allows 
enzymatic biosensors to be utilized in many fields like health care, food industry, 
and environmental monitoring.  
 
1.2.1.1 Enzyme kinetics 
The majority of enzymatic reactions can be described with the Michaelis-
Menten enzyme kinetics model. In this case, the enzyme binds the substrate to 
form a complex and then the product is released whereas the enzyme is returned 
to its original form. This model can be divided into two specific stages: when the 
concentration of substrate is low, the reaction rate is linearly correlated to the 
concentration of substrate, whereas at high substrate concentration, the substrate 
saturates the enzyme and the reaction rate does not increase as the concentration 
of substrate increases. Two constants, KM and Vmax, are usually used to 
characterize an enzymatic catalysis system. KM, the Michaelis constant, is the 
substrate concentration at half-maximum reaction rate, where Vmax is the maximum 
reaction rate. The equation of the Michaelis-Menten enzyme kinetics model is 
shown as Equation 1.1. 
𝑣𝑣 = 𝑉𝑉𝑚𝑚𝑚𝑚𝑚𝑚[𝑆𝑆]
𝐾𝐾𝑀𝑀+[𝑆𝑆]  [1.1] 
However, a significant amount of enzymes utilize more than one substrate 
and the turnover of those two substrate by the same enzyme is related. For 
instance, succinate dehydrogenase oxidizes succinate while it reduces 
ubiquonone. In this case, because of the dependency of those two reactions, the 





Menten kinetics model. In this case, a double-placement mechanism is used to 
describe such a mechanism. The double-placement mechanism is more 
commonly characterized figuratively, most commonly with the Lineweaver-Burk 
plot, which will be described in the following section. 
 
1.2.1.2 Lineweaver-Burk plot 
The Lineweaver-Burk plot is commonly used to characterize a double-
placement enzyme kinetics; it is also used to distinguish different enzyme inhibition 
types. The equation of the Lineweaver-Burk plot is derived from rearranging the 





1[𝑆𝑆] + 1𝑉𝑉𝑚𝑚𝑚𝑚𝑚𝑚  [1.2] 
The Lineweaver-Burk plot can be used to distinguish different double-
placement enzymatic reactions and enzyme inhibition. The double-placement 
enzyme reaction can be put into two categories depending on whether a ternary 
complex is formed during the reaction process or not. For double-placement 
reaction involving formation of a ternary complex, the enzyme binds both the 
substrates before releasing any product, whereas the binding of two substrate may 
or may not occur in a specific order. In the Lineweaver-Burk plot of a double-
placement enzymatic reaction, when 1/V is plotted against 1/[S1] under different 
[S2], the Lineweaver-Burk plot is a series of intersecting lines.  
Another case of double-placement enzymatic reaction is the Ping-Pong 
reaction, where the two reactions were sequential. In the Ping-Pong reaction, the 





enzyme turns over one of the substrates to one of the products while itself turning 
into an intermediate configuration; the intermediate enzyme then turns over the 
other substrate and returns to its original form. In the Lineweaver-Burk plot of a 
Ping-Pong reaction, when 1/V is plotted against 1/[S1] under different [S2], the 
Lineweaver-Burk plot is a series of parallel lines.  
Other than the Lineweaver-Burk plot, many other graphic tools have been 
used for analyzing enzyme kinetics. Aside from the most commonly used 
Lineweaver-Burk plot, there is the Eadie–Hofstee plot and Hanes–Woolf plot. The 
equations of the Eadie-Hofstee plot and Hanes-Woolf plot are shown individually 
in Equation 1.3 and 1.4. 








Comparing to the Linewear-Burk plot, in the Eadie-Hofstee plot, Vmax is 
determined by the intersect and KM is determined by the slope. The Hanes-Woolf 
plot is the most complicated in terms of determining kinetics parameters, where 
Vmax can be determined from the slope of the plot and KM/Vmax can be determined 
from the intersect. Among all those graphic methods of determining kinetics 
parameters, the Linewear-Burk plot represents the most convenient method and 
thus is most commonly used. 
 
1.2.1.3 Enzyme inhibition 
The inhibition of enzymes can be classified into 2 categories, reversible 





either binds to the enzyme or the enzyme substrate complex without causing 
destruction of the enzyme. In the case of irreversible inhibition, the binding of 
inhibitor and enzyme dysfunction the enzyme. A model to resolve the type of 
inhibition can be developed by analyzing the inhibition kinetics of a specific enzyme.  
Most commonly, enzyme kinetics fit the Michaelis-Menten kinetics model. 
In this case, the enzyme binds the substrate to form a complex and then the 
product is released while the enzyme is returned to its original form. This model 
can be divided into two specific stages: when the concentration of the substrate is 
low, the reaction rate is linearly correlated to the concentration of the substrate, 
while at high substrate concentration, the substrate saturates the enzyme and the 
reaction rate does not increase as the concentration of the substrate increases. 
Two constants, KM and Vmax, are usually used to characterize an enzymatic 
catalysis system. KM, the Michaelis constant, is the substrate concentration at half-
maximum reaction rate, where Vmax is the maximum reaction rate. 
Reversible inhibition can be further classified into 3 sub-categories, 
competitive inhibition, uncompetitive inhibition, and noncompetitive inhibition. For 
competitive inhibition, the inhibitor directly binds to the active site of the enzyme; 
therefore, it acts as a competitor to the substrate. An indication of competitive 
inhibition is that KM decreases while Vmax stays the same. The Lineweaver-Burk 
plot of competitive inhibition under different concentration of inhibitors is a series 
of lines that converge on the y-axis. Uncompetitive inhibition happens when the 
inhibitor only binds to the enzyme-substrate complex. In this case, both KM and 





different concentration of inhibitors is a series of parallel lines. In the case of 
noncompetitive inhibition, the inhibitor binds to a non-active site of the enzyme and 
changes the enzyme configuration, rendering the enzyme incapable of binding the 
substrate. Vmax decreases while KM stays the same in the presence of a non-
competitive inhibitor. The Lineweaver-Burk plot of noncompetitive inhibition under 
different concentration of inhibitors is a series of lines that converge on the x-axis. 
The last type of reversible enzyme inhibition is mixed inhibition, in which a 
combination of any of the above types of inhibition occur together, and the 
Lineweaver-Burk plot of mixed inhibition usually intersects but not on any of the 
axes. 
 
1.2.1.4 Enzyme immobilization techniques 
In the earliest era of biosensors, enzymes were utilized in solubilized 
form.50-52 While solubilized enzyme is still used occasionally, this method of 
enzyme utilization is resource-demanding and the performance is subpar. To solve 
this problem, enzyme immobilization techniques were introduced. Immobilization 
of enzyme increases the surface concentration of enzyme on the transducer, as 
well as maintaining the biological activity of enzyme. The immobilization methods 
used in enzymatic biosensors include physical adsorption, covalent bonding, 
entrapping, and crosslinking.53 
Physical adsorption is the easiest and most direct method of enzyme 
immobilization. Enzymes can adsorb on surfaces via Van Der Waal’s forces or 





still being used today. Some of the enzymes that can be fabricated into a biosensor 
by this method include urease, glucose oxidase, and horseradish peroxidase.54-56 
Enzyme entrapment usually involves immobilizing enzymes within a three-
dimensional (3-D) network. Many methods and materials have been reported for 
enzyme entrapment. Electropolymerization of compounds such as polyaniline and 
polypyrrole has been extensively used with enzymes like glucose oxidase,57-58 
horseradish peroxidase,59 and uricase.60-61 These conductive polymers offer a 
network for 3-D electron transfer between the enzymes and the electrode. 
Moreover, they allow a much better spatial utilization of enzymes, thus significantly 
increasing sensor response. In some other cases, a sol-gel network is commonly 
utilized. This category of enzyme entrapment exhibits great abundancy in terms of 
material choices. Sol-gel immobilization techniques use materials like silane 
derivatives, polysaccharide, etc. Among these materials, polysaccharide 
derivatives have shown good biocompatibility. It has been reported that enzymes 
entrapped in agarose (a polysaccharide derivative) can maintain activity for 
months.62-63 Carbon paste and clay are also commonly used materials for enzyme 
entrapping. The performance of carbon paste can be manipulated by utilizing 
different binders, or by surface modification of the carbon.64-65 As for clay, its 
inorganic matrix provides abundant surface area for entrapping enzymes. Many 
different enzymatic biosensors have been reported utilizing clay as an 
immobilization material for analytes such as glucose,66 H2O2,67 and urea.68 
Crosslinking is defined as linking the enzyme to a surface with a crosslinking 





redox mediator is needed, crosslinking of the redox active polymer is involved. The 
crosslinking of such polymers creates a network that entraps the enzymes. The 
backbone of the polymer network expands the surface area of the electrode and 
allows charge to pass along the backbone by rapid self-exchange so higher current 
density can be obtained. 
 
1.2.1.5 Applications of enzymatic biosensors 
Applications of biosensors have always been the primary focus of this type 
of research. Glucose biosensors were the first kind of biosensor put into application 
and now possess a market of more than $2 billion.72 In the concept of an artificial 
pancreas, biosensors for blood sugar monitoring are linked to an insulin pump as 
an automatic way to inject insulin when high blood sugar level is detected.73 
However, commercial applications of biosensors are rarely seen for other types of 
biosensor other than glucose biosensors. 
Another potential field of application for enzymatic biosensors is 
environmental monitoring, where enzymatic biosensors show comparable 
response to traditional detecting methods. However, commercial applications in 
the category are rarely seen for biosensors, because they often lack specificity due 
to the difficulty of separating and distinguishing different toxins. However, the 
application of enzymatic biosensors in environmental science and engineering is 






1.2.1.6 Laccase-based biosensors 
Self-powered biosensors are among the most promising applications for 
biosensors and they are mostly constructed as enzymatic fuel cells. For enzymatic 
fuel cells, the enzyme options for enzymatic anodes are abundant, including 
glucose oxidase, glucose dehydrogenase, alcohol dehydrogenase, etc. However, 
the choices for biocathodes are limited. At present, the only enzymatic biocathodes 
reported extensively employ laccase or bilirubin oxidase. Compared to bilirubin 
oxidase, laccase is reported to be more sensitive to many different ions and 
inhibitors, such as azide, Cl-, and F-, making it a feasible biosensor material. 
Laccase contains 3 copper centers: the T1 copper center is responsible for 
oxidizing phenol derivatives, while the T2 and T3 copper centers form a trinuclear 
(TNC) center which is responsible for reducing oxygen to water. Since laccase 
utilizes electrochemical active phenonl derivatives, such as 4-methoxybenzyl 
alcohol, 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) and phenothiazine, 
as substrates, mediated electron transfer for laccase is feasible.74 However, the 
T1 copper center of laccase is only 0.65 nm from the outside of laccase, which 
also makes it possible for laccase to perform direct electron transfer.75 Direct 
electron transfer, in comparison to mediated electron transfer, does not undergo a 
potential loss between the enzyme and mediator and, therefore, theoretically 
provides higher energy output. 
Although laccase itself possesses the capability of directly electron transfer, 
it does require a specific spatial arrangement between the enzyme and electrode 





electron transport efficiency, different docking techniques have been developed. 
Among these techniques, the most successful ones involve immobilizing 
anthracene on carbon nanotubes with either π-π stacking via pyrene76 or by 
covalently binding anthracene directly on carbon nanotubes.77 
Laccase has been studied as a biorecognition material for phenol 
compounds as part of wine analysis. Another application of laccase as a biosensor 
is oxygen sensing. For both of these kinds of analysis, laccase utilizes the analyte 
as substrate. As described before, laccase is also sensitive to different inhibitor 
analytes.  The inhibition of laccase by different inhibitors can be put into a few 
different categories: the inhibition of laccase by F- is irreversible inhibition, while 
laccase inhibition by Cl- can be classified as competitive inhibition, and inhibition 
by H2O2 can be classified as noncompetitive inhibition.39 Given the sensitivity of 
laccase to inhibitors, it has potential as an inhibition-based biosensor. For example, 
H2O2 could be identified by the fact that laccase regains activity with the addition 
of catalase. 
 
1.2.2 Microbial biosensors 
Compared to enzymatic biosensors, microbial biosensors possess 
advantages like better stability and good biomaterial accessibility. Just like 
enzymatic biosensors, microbial biosensors have an abundant choice of sensing 
motifs, such as Pseudomonas putida,78 E coli,79 and Acidithiobacillus 
ferrooxidans.80 Various analytes have been reported for microbial biosensors; 





the health care field is rare, mostly due to possible risk of infection.  
 
1.2.2.1 Microbial cell immobilization 
In terms of immobilization techniques, microbial cells offer more options 
than enzymes. Techniques used for enzyme immobilization, such as entrapment 
and absorption, can also be applied to microbial cells. However, unlike enzymes, 
which are single proteins, microbial cells contain a series of proteins for their 
biofunctionality and they are capable of growing and forming biofilms on different 
surfaces; therefore, they have the capability of attaching themselves on the 
transducer surface when proper stimuli is applied.  
Biofilms are observed for multiple microbial species, such as Geobacter and 
Shewanella. In many cases, the formation of a biofilm is observed under specific 
stimuli - usually an electric potential. The term “biofilm” is more of a general 
concept and it includes different types of microbial cell “self-immobilization.” The 
exact mechanism of electron transfer in biofilms is complicated and differs between 
each individual microbial species. Conductive pili have been suggested by some 
researchers to be part of the mechanism of biofilm electrochemistry for species 
such as Shewanella, while other researchers claim that cytochromes and 
riboflavins are to be the responsible electrochemically active species for the same 
species under different immobilizing conditions.81 It is hypothesized that the 
electrochemical mechanism of a biofilm is altered by the nature of the electrode 
surface; for example, carbon is selective to riboflavins whereas ITO is selective to 





conclusion has not been drawn yet. 
 
1.2.2.2 Applications of microbial biosensors 
Abundant research has been performed for microbial biosensors. The 
analysis of organophosphate chemicals by microbial biosensors has been 
extensively studied.1 For many microbial biosensors, the detection of 
organophosphate compounds relies on surface active proteins, such as 
organophosphorus hydrolase.40 This protein has shown selectivity and sensitivity 
to many different organophosphate pesticides such as paraxon, parathion, and 
methyl parathion.82-83 Another application of microbial biosensors is the 
measurement of Biochemical Oxygen Demand (BOD), a vital parameter in 
wastewater treatment. Instead of the traditional BOD measurement, which usually 
takes about a week, the process can be shortened by directly immobilizing 
microbes on the electrode. For instance, Kara et al. immobilized P. Syringae on an 
oxygen probe and obtained responses as fast as 3-5 min.84  
Microbial biosensors have also shown potential for the detection of other 
environmental toxins. Phenols can be detected by P. putida85 or E. coli.86 Moreover, 
it is also reported that microbial biosensors can be used for detecting heavy metals, 
such as Cu2+ and Cr3+.80,87 
 
1.2.3 Organelle biosensors 
Organelle biosensors primarily involve thylakoids and mitochondria. The 





microbial biosensor and the sensitivity and fast response time of enzymatic 
biosensors. The studies of electrochemically active species for organelle 
biosensors are similar to those for microbial biosensors. In studies involving 
organelles, cytochromes and quinones are the top pick for electrochemically active 
species.88-91 Thylakoids have been studied for a pesticide biosensor and have 
shown competent sensitivity.92 Mitochondria have also been tested as biosensors 
for pesticides89 and nitroaromatic explosives, which are mitochondria 
uncouplers.88 Mitochondria are also extensively studied in health-care-related 
topics for their vital role in apoptosis.93-95 
 
1.3 Mitochondrial biosensors 
Mitochondria are organelles that are responsible for the complete oxidation 
of pyruvate and synthesis of ATP. Mitochondria carry a complete set of Kreb’s 
cycle enzymes for the complete oxidation of pyruvate. Mitochondria can also utilize 
fatty acids and amino acids as substrates. The complete oxidation of substrate in 
mitochondria usually starts with the transformation of the original substrate into 
acetyl-CoA; acetyl-CoA further enter the Krebs cycle for complete oxidation and 
the ATP synthesis is performed by the mitochondrial electron transport chain 
(ETC). 
The electron transport chain is the key component in mitochondria for ATP 
synthesis. The electron transport chain contains NADH-ubiquinone 
oxidoreductase (complex I), acetyl-CoA-ubiquinone oxidoreductase (complex II), 





(complex IV). Complex I and II are FAD containing proteins that pass electrons to 
ubiquinone, which is then oxidized by complex III. Complex III then reduces 
cytochrome c, a redox active protein residing between the mitochondrial inner and 
outer membranes, and the electron is finally passed to complex IV. Finally, 
complex IV reduces oxygen to water. The ATP synthase (complex V) is usually 
considered part of the electron transport chain, although no electron is passed to 
it from other complexes in the electron transport chain. A demonstration of the 
structure of mitochondrial electron transport chain is shown in Figure 1.2. 
Mitochondria contain two membranes, an outer membrane and an inner 
membrane. In the process of total oxidation of pyruvate, fatty acids, and amino 
acids, complexes I, II, and IV pump protons from the mitochondrial matrix to the 
mitochondrial intermembrane space (the space between the mitochondrial outer 
and inner membranes), creating a proton gradient between the mitochondrial 
matrix and intermembrane space. The mitochondrial complex V utilizes the proton 
gradient generated by other complexes in the mitochondrial electron transport 
chain to synthesize ATP.  
The fact that mitochondria contain multiple electrochemically active species, 
such as ubiquinone, cytochrome c, and cytochrome P450, makes it possible to 
make mitochondria into an electrochemical biosensor. The first electrochemistry 
of mitochondria, observed on a pyrolytic graphite electrode surface, was credited 
to cytochrome c and FAD/FADH2.96 Further study suggests that ubiquinone is 
more likely to be the electrochemically active species, as demonstrated by 





the electrochemical behavior.91 After the achievement of mitochondrial 
electrochemistry, mitochondria have been tested against different environmental 
toxins, such as parathion, paraquat, and malathion.89,97 Mitochondria have also 
been shown to be sensitive to nitroaromatic compounds, a category of explosives 
that are also mitochondrial uncouplers, thus making them applicable to a self-
powered biosensor for explosives sensing.88 
 
1.3.1 Mitochondria uncoupling  
As mentioned previously, mitochondrial complex V relies on the proton 
gradient between the mitochondrial matrix and intermembrane space to synthesize 
ATP. When mitochondria are healthy, the inner membrane itself is non-permeable 
to protons and the only way for protons to transport through the mitochondrial inner 
membrane is via complexes I, III, IV, and V. Proton outflow is regulated by 
complexes I, III, and IV, and proton inflow is regulated by complex V. When 
mitochondrial ETC are coupled (also described as when mitochondria are coupled), 
the activity of complex V is directly related to the activity of the rest of the 
mitochondrial ETC. However, when mitochondria are uncoupled due to either 
apoptosis, mitochondrial defect, or other illness, the permeability of the 
mitochondrial inner membrane is increased, the proton gradient is partially or 
totally lost, and thus the link between complex V’s activity and the other ETC 
complexes is lost. This phenomenon is called mitochondria uncoupling. 
The characterization of mitochondrial metabolism is performed by 





the mitochondrial electron transport chain or while uncoupling the whole 
mitochondria. A typical response under the inhibition of any part of the 
mitochondrial electron transport chain, even complex V, will be a decrease in the 
mitochondrial oxygen consumption rate, while the uncoupling of mitochondria will 
cause the mitochondrial oxygen consumption rate to reach its maximum value.  
The mechanism of mitochondrial uncoupling is under extensive study and 
now, a commonly accepted theory is that mitochondrial uncoupling is performed 
by uncoupling proteins.98 In healthy mitochondria, uncoupling proteins are 
responsible for regulating tissue temperature, as uncoupled respiration leads to 
heat production instead of ATP production. Another role of uncoupling proteins is 
to suppress the generation of reactive oxygen species,98 which is why 
mitochondrial uncoupling is usually the first indication of mitochondrial apoptosis. 
 
1.4 Overview of the dissertation 
This research focuses on the mechanism and application of two different 
types of biosensors, a laccase-based biosensor for arsenic sensing (Chapter 2) 
and a mitochondrial biosensor for pesticide sensing and early diseases diagnosis 
(Chapters 3 and 4). 
In Chapter 2, the inhibition of laccase by As3+/5+ was first observed 
electrochemically via utilization of a laccase-modified electrode on anthracene-
doped multiwall carbon nanotube-modified electrodes. The inhibition mechanism 
was determined by Lineweaver-Burk plot and Michaelis-Menten nonlinear 





0.91 ± 0.07 mV/mM for arsenite and 0.98 ± 0.02 mV/mM for arsenate and the 
detection limit was determined as 13 µM for arsenite and 132 µM for arsenate.   
In Chapter 3, the isolation of coupled mitochondria from bovine heart is 
reported. The coupled mitochondria were tested against one of the popular 
organophosphate pesticides, malathion, and were shown as an on-and-off 
biosensor with a detection limit of 20 nM. It was also determined that although 
malathion is reported as both a mitochondrial uncoupler and inhibitor, the 
mitochondrial toxicity of malathion observed via electrochemical methods is more 
prone to be classified as an uncoupler for mitochondria. 
In Chapter 4, a novel mechanism was discovered for mitochondrial 
inhibition monitored electrochemically. Different inhibitors (rotenone and 
permethrin on complex I, carboxin on complex II, antimycin on complex III) were 
tested with mitochondria-modified electrodes and similar electrochemical 
responses were observed for all three inhibitors, which contradicts the previously 
accepted mechanism that the electrochemically active species in mitochondria is 
ubiquinone. Another category of electrochemically active species, riboflavin 
derivatives, were tested individually and in combination with ubiquinone. It was 
demonstrated that the effect of riboflavin derivatives on the observed ubiquinone 
electrochemical signal changed depending upon which solvent was used to modify 
electrodes. When aqueous casting solution was used, the presence of riboflavin 
derivatives induced a decrease in ubiquinone signal. When a nonaqueous casting 
solvent (ethanol) or lipid membrane was used, the ubiquinone signal was 





riboflavin species under inhibition, indicates that mitochondrial electrochemistry is 
caused by a combination of riboflavin derivatives and ubiquinone. 
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Figure 1.1: Flow chart of biosensing process, A) a system contains analyte 
and interference components, B) those components interact with the 
biosensor, C) the biosensor recognizes the analyte, D) the transducer 
generates a signal.  
 










Figure 1.2: Structure of mitochondrial electron transport chain, showing 
mitochondrial inner membrane (yellow line), mitochondrial complex I (purple), 
complex II (green), complex III (yellow), complex IV (orange), complex V (red), 
ubiquinone (cyan), and cytochrome c (brown). 
 Reprinted (adapted) with permission from Analytical Chemistry 88.6 (2016): 3243-3248. 







LACCASE INHIBITION BY ARSENITE/ARSENATE: 
DETERMINATION OF INHIBITION MECHANISM 
 AND PRELIMINARY APPLICATION TO A  
SELF-POWERED BIOSENSOR 
 
In this chapter, the reversible inhibition of laccase by arsenite (As3+) and 
arsenate (As5+) is reported. Oxygen-reducing laccase bioelectrodes were found to 
be inhibited by both arsenic species for direct electron-transfer bioelectrodes 
(using anthracene functionalities for enzymatic orientation) and for mediated 
electron-transfer bioelectrodes [using 2,2'-azino-bis(3-ethylbenzothiazoline-6-
sulfonic acid) (ABTS) as an electron mediator]. Both arsenic species were 
determined to behave via a mixed inhibition model (behaving closely to that of 
uncompetitive inhibitors) when evaluated spectrophotometrically using ABTS as 
the electron donor. Finally, laccase biocathodes were employed within an 
enzymatic fuel cell, yielding a self-powered biosensor for arsenite and arsenate. 
This conceptual self-powered arsenic biosensor demonstrated limit of detection 









Arsenic is a commonly occurring groundwater pollutant largely originating 
from mines, industrial waste and other natural processes.1-2 Arsenic is present in 
the environment in both organic and inorganic forms. Among polluting inorganic 
arsenic species, arsenate and arsenite are the most common and toxic forms in 
groundwater,3 therefore their environmental monitoring is necessary. 
Electrochemical monitoring of arsenic in water has been extensively studied and 
different electrochemical techniques have been evaluated for their suitability of 
detecting arsenic in environmental samples, such as polarography,4-5 and cathodic 
or anodic stripping voltammetry.6-7 Electrochemical detection techniques for 
arsenic have been transplanted to microarray platforms aimed at portable and 
field-deployable sensing purposes as opposed to high sensitivity applications 
(such as spectroscopic and chromatographic techniques), where portability is 
often troublesome.8-9 
Electrochemical arsenic sensors typically consist of a three-electrode 
system including a working, reference and counter electrode. A potentiostat is 
required to input energy into the cell and regulate the sensor. Additionally, a three-
electrode device is bulky, which is unfavorable for field applications and 






An enzymatic fuel cell (EFC) utilizes enzymes as biocatalytic alternatives to 
commonly used metal catalysts, such as platinum. EFCs are compact two-
electrode systems that generate power. Self-powered biosensors based on EFC 
technology thus do not require an external electrical energy source.10-22 Previous 
studies on self-powered biosensors have demonstrated that they are able to be 
fueled or inhibited by an analyte.23-28 EFCs that are fueled by glucose have been 
extensively reported29-31 and some have been extended to self-powered 
biosensors.32-34 A large number of glucose/O2 EFCs utilize laccase as the cathodic 
biocatalyst for O2 reduction to H2O.33,35-40 Herein, we report the first experimental 
evidence of the enzymatic inhibition of laccase by both arsenite and arsenate 
(Figure 2.1). The enzymatic inhibition model was elucidated using ABTS as a 
substrate for colorimetric assays. Further, laccase was combined with flavin 
adenine dinucleotide-dependent glucose dehydrogenase (FAD-GDH) to yield a 
glucose/O2 EFC that is able to operate as a self-powered biosensor for arsenate 
and arsenite detection. 
 
2.2 Experimental 
2.2.1 Chemicals and materials 
FAD-dependent glucose dehydrogenase (FAD-GDH) was purchased from 
Sekesui Diagnostics (U.K.) and used as received. Toray carbon paper was 
purchased from Fuel Cell Earth (U.S.A.) and used as received. Hydroxyl-
functionalized multiwalled carbon nanotubes were purchased from Cheaptubes 





Nafion) was prepared based on a previously reported procedure.41 All other 
chemicals were purchased from Sigma-Aldrich (reagent grade) and used as 
received. 
 
2.2.2 Laccase and FAD-GDH bioelectrodes fabrication 
Both laccase and FAD-GDH bioelectrodes are fabricated based on 
previously published procedures. Laccase biocathode is fabricated based on the 
following procedure: 20 mg/mL laccase in pH 5.5 citrate-phosphate buffer was 
mixed with 100 mg/mL anthracene-functionalized multiwalled carbon nanotube 
(Ac-MWCNT) and vortex-mixed for a total of 4 min along with sonication for a total 
of 1 min.41 The resulting mixture was then mixed with 25% v/v TBAB-Nafion, 
vortex-mixed for an additional minute, and sonicated for an additional 15 s. Then 
approximately 33 µL of the mixture is applied to a 1 cm2 square of Toray carbon 
paper via a brush and dried at room temperature before evaluation. 
For the FAD-GDH bioanode fabrication, dimethyferrocene-functionlized 
linear poly(ethylenimine) (FeMe2-LPEI) was synthesized and FAD-GDH bioanode 
were prepared, as previously reported.42 The FAD-GDH bioanodes were prepared 
by mixing 10 mg/mL ferrocene redox polymer, 30 mg/mL FAD-GDH and 10% v/v 
ethylene glycol diglycidyl ether (EGDGE) in a ratio of 56:24:3. A 10 µL aliquot of 
the mixture was applied to a 0.25 cm2 Toray paper electrode surface and dried for 






2.2.3 UV-Vis assay for determining laccase inhibition mechanism 
UV-Vis kinetic assays were performed on a BioTex Synergy HTX multiplate 
reader. The absorbance of ABTS oxidation was monitored at 420 nm with different 
substrate concentrations (500, 100, 40, 20, 10, 4 µM). The concentrations of 
arsenite and arsenate tested were 0.5, 1, 2, 4, 8, 12 mM, and the concentration of 
laccase was 13 µg/mL. All tests were performed in citrate-phosphate buffer (200 
mM pH 5.5). 
 
2.2.4 Electrochemical measurements 
A three-electrode configuration was used for cyclic voltammetry and 
amperometric i–t experiments. A saturated calomel electrode (SCE) was used as 
the reference electrode, and a platinum mesh was used as the counter electrode. 
Enzymatic fuel cells were evaluated by galvanostatically drawing increasing 
current at a slow ramp rate (0.1 µA/s) until short circuit. The self-powered 
biosensor was evaluated by continuously drawing 10% of its maximum current 
density of the enzymatic fuel cell and monitoring the potential difference with 
increasing concentrations of arsenite and arsenate. All experiments were 
performed at 22 ± 1 °C. 
 
2.3 Results and discussion 
2.3.1 Determination of laccase inhibition reversibility 
Laccase is known to be able to undergo both mediated (MET) and direct 





orientate the type I copper center of laccase toward the electrode surface.48 This 
favorable orientation results in DET of laccase, yielding a bioelectrode that is able 
to undergo the direct bioelectrocatalytic reduction of O2 to H2O (Figure 2.2). 
The reversibility of arsenite and arsenate inhibition to laccase was firstly 
investigated by evaluation of laccase bioelectrodes in buffer (in the absence of 
arsenate and arsenite). Immersion of a laccase bioelectrode in buffer that contains 
dissolved O2 results in a catalytic reductive wave, due to the direct 
bioelectrocatalytic reduction of O2 to H2O by laccase (onset potential of 
approximately +600 mV vs SCE). The addition of arsenite or arsenate yields a 
decreased catalytic response for O2 reduction, due to enzyme inhibition. Replacing 
the buffer with arsenite/arsenate-free buffer returns the catalytic current generated 
by O2 reduction to approximately 100%, demonstrating the reversibility of the 
inhibition mechanism. 
 
2.3.2 Determination of laccase inhibition mechanism of  
arsenite and arsenate via UV-Vis colorimetric assay 
After electrochemically determining the reversibility of laccase inhibition by 
arsenate and arsenite, UV-Vis colorimetric assays were performed utilizing ABTS 
as electron donor. An apparent rate versus arsenite and arsenate is presented in 
Figure 2.3. As shown in Figure 2.3, the increasing of arsenite or arsenate 
concentration (from 0 to 12 mM) leads to decrease of the maximum apparent 
reaction rate (Vmax) from 1.02 ± 0.08 to 0.13 ± 0.00 abs/min for arsenite and 1.16 
± 0.06 to 0.66 ± 0.04 abs/min for arsenate; a detailed description of the Vmax value 





Additionally, the Michaelis constant (KM) also decreases, which is indicative 
of an uncompetitive inhibition mechanism.48-49 To further elucidate the inhibition 
mechanism, Lineweaver-Burk double-reciprocal plots were evaluated for differing 
concentrations of each inhibitor, as shown in Figure 2.4. A convergence of data 
sets on the Y-axis of Lineweaver-Burk plots is typical of a competitive inhibition 
mechanism, while convergence of related data sets on the X-axis is indicative of a 
non-competitive inhibition mechanism. Analysis of the Lineweaver-Burk double-
reciprocal plots indicate a mixed inhibition model (incorporating both uncompetitive 
and noncompetitive inhibition models), although the nonlinear regression 
performed above suggest the inhibition model lay nearer to that of an 
uncompetitive inhibition model. The Ki value for laccase inhibition by arsenic was  
determined for a mixed inhibition model (by nonlinear regression), with 2.3 ± 1.4 
mM reported for arsenite and 15.4 ± 10.1 mM reported for arsenate. R2 values for 
individual Michaelis-Menten fittings are reported in Table 2.2. An uncompetitive 
inhibition model fit by nonlinear regression yielded overall R2 values of 0.9617 for 
arsenate and 0.9420 for arsenite (n = 3). 
 
2.3.3 Laccase inhibition monitored by amperometry 
Subsequently, amperometric i-t analysis (Figure 2.5) was performed at 0.2 
V (vs. SCE) with consecutive injections of either arsenate or arsenite. At this 
potential, O2 is reduced to H2O by the laccase biocathodes. Following the 
introduction of oxygen into the nitrogen-purged buffer, a catalytic current is 
observed corresponding to the direct bioelectrocatalytic of reduction of oxygen by 





catalytic current is observed with arsenite/arsenate concentrations ranging from 
0.5 to 11 mM. The corresponding catalytic currents decrease for the laccase 
biocathodes in the range of 5-90% current for arsenite and 2-30% current for 
arsenate. The laccase bioelectrodes exhibited sensitivities of 46.9 ± 7.0 and 10.6 
± 1.2 µA/mM for arsenite and arsenate, respectively. Their corresponding linear 
dynamic ranges were approximately 0.5 – 5 mM arsenite (R2 = 0.9923) and 0.5 - 
8 mM arsenate (R2 = 0.9894). 
Finally, additional amperometric experiments were performed to further 
elucidate the enzymatic inhibition model, as shown in Figure 2.6. Laccase 
bioelectrodes were prepared in the absence of anthracene functionalities on the 
MWCNTs (to eliminate DET contributions), and enzymatic bioelectrocatalysis was 
facilitated with injections of ABTS as the electron mediator and substrate (under 
constant O2 concentrations) in the presence of arsenite (Figure 2.6A) and arsenate 
(Figure 2.6B). R2 values for multiple inhibition models applied to this data by 
nonlinear regression fits are presented in Table 2.3, where mixed inhibition models 
had the greatest correlation for both inhibitors. 
 
2.3.4 Self-Powered laccase arsenite and arsenate sensor 
Following the determination of the inhibition mechanism for laccase, 
previously-reported FAD-GDH bioanodes (incorporating a ferrocene redox 
polymer for MET) were coupled with laccase biocathodes (undergoing DET), 
yielding glucose/O2 EFCs operating on 100 mM glucose.42 The bioanodes and 
biocathodes were prepared on Toray carbon paper electrodes, with the 





sensitivity). Figure 2.7 demonstrates the mediated bioelectrocatalytic oxidation of 
glucose by FAD-GDH, where the presence of arsenite and arsenate do not affect 
enzymatic activity. Figure 2.8A presents a polarization and resulting power curve 
for the glucose/O2 EFC, in the absence and presence of arsenite/arsenate. EFCs 
were evaluated galvanostatically, by drawing gradually increasing current from the 
EFC until short circuit (ramp rate of 1 µA/s). The EFCs possessed open circuit 
potentials (OCPs) of 723.3 ± 4.5 mV. The maximum current and power densities 
were 289.7 ± 12.4 µA cm-2 and 57.2 ± 1.9 µW cm-2 (mean ± standard deviation, n 
= 3). 
As a self-powered sensor that does not require any external energy source 
to operate, only 10% of the maximum current is drawn from the glucose/O2 EFC 
and the potential difference is monitored as a function of time (Figure 2.8 B and C). 
With 10% of the maximum current withdrawn from the biofuel cell, it can be seen 
that the biofuel cell retains approximately 73% of its OCP. Successive aliquots of 
arsenite or arsenate are injected into the electrolyte/buffer/fuel solution, which 
results in a decrease in potential difference of the EFC. For arsenite or arsenate 
at a final concentration of 1-20 mM, a decrease in the potential difference of the 
EFC of 20 mV is observed. To eliminate variation between each EFC, the 
percentage change of the initial OCP of EFC is averaged and plotted. 
Differences in the inhibitory effects of arsenic for the self-powered EFC 
experiments and the amperometric laccase experiments are due to the 
experimental conditions employed (potentiostatic and galvanostatic), where 





bioelectrode. The continuously changing potential difference between the T1 Cu 
site of laccase and the electrode architecture continuously alters the catalytic 




In conclusion, this chapter reports the enzymatic inhibition of laccase and 
laccase bioelectrodes (DET type) by both arsenite and arsenate, for which a mixed 
(with preference to uncompetitive inhibition) inhibition model was determined by 
UV-Vis spectrophotometric assays. The laccase biocathodes were then employed 
within a glucose/O2 EFC, yielding a self-powered arsenite/arsenate biosensor. The 
device possessed LODs of 13 µM for arsenite and 132 µM for arsenate, with 
sensitivities of 0.91 ± 0.07 mV/mM for arsenite and 0.98 ± 0.02 mV/mM for 
arsenate, capable of detecting acute arsenite and arsenate poisoning.52 Linear 
dynamic ranges for the EFCs were evaluated for 1 – 20 mM arsenite (R2 = 0.9934) 
and 1 – 8 mM arsenate (R2 = 0.9810). Further, the device only operated at 10% 
current draw of the maximum current density of the EFC. 
While this conceptual study demonstrates how the inhibition of laccase and 
laccase bioelectrodes by arsenite and arsenate can yield a self-powered biosensor 
for their detection, future studies will address the suitability of this system in actual 
field samples as well as develop an array system to investigate the possible effect 
of other contaminants on the self-powered biosensor (i.e. fluoride). Interference 





orientation moiety has been demonstrated to be able to out-compete chloride 
inhibition (which acts as a competitive inhibitor).53 
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Figure 2.1: Direct electron-transfer-type laccase bioelectrodes are 














Figure 2.2: Representative cyclic voltammograms of laccase bioelectrodes in 
citrate-phosphate buffer (200 mM, pH 5.5, stirred) in the presence of 50 mM 
arsenate (blue line) or 50 mM arsenite (red line). Inhibited laccase bioelectrodes 
were rinsed and evaluated in fresh citrate-phosphate buffer (representative data 
set presented as dashed black line for As3+ and As5+ inhibited bioelectrodes). All 








Figure 2.3: Spectroscopic determination of apparent Michaelis-Menten 
kinetics for the reduction of ABTS with different concentrations of A) 
arsenite or B) arsenate present. Kinetics were determined at pH 5.5, by 










Figure 2.4: Lineweaver-Burk double reciprocal plot of the reduction of O2 by 
laccase, monitored by following the absorbance of ABTS in citrate-
phosphate buffer with differing concentrations of A) arsenite and B) 






Figure 2.5: Representative amperometric i-t curves of laccase bioelectrodes 
with successive injections of A) arsenite and B) arsenate. (Inset figure: 
Averaged percentage change of each laccase electrode with injections of A) 
arsenite and B) arsenate). Experiments were performed at pH 5.5 (200 mM 










Figure 2.6: Apparent Michealis-Menten kinetics of laccase determined via 
amperometry at 0 V vs. SCE using ABTS as substrate at different A) 
arsenite and B) arsenate concentrations. Electrochemical measurements 













Figure 2.7: Representative cyclic voltammograms of FAD-GDH bioanodes in 
citrate-phosphate buffer (pH 5.5, 200 mM) without glucose (black line), with 100 
mM glucose (blue line), with 100 mM glucose and 5 mM arsenite (red line), and 











Figure 2.8: A) Representative polarization curve for a glucose/O2 EFC (black 
solid line), operating in citrate-phosphate buffer (pH 5.5, 200 mM, stirred) 
containing 100 mM glucose. Corresponding power curves are presented as 
dashed lines. EFCs were also operated in the presence of 20 mM arsenite 
(red lines) and 20 mM arsenate (blue lines). B) Representative 
chronopotentiometric traces for EFCs operating at 10% current draw with 
sequential injections of 1 mM arsenite. C) Representative 
chronopotentiometric traces for EFCs operating at 10% current draw with 
sequential injections of 1 mM arsenate. Inset graphs present the averaged 
percentage change of the EFCs’ potential differences with arsenic injections. 




















[Arsenite] 0 mM 0.5 mM 1 mM 2 mM 4 mM 8 mM 12 mM 
Vmax (mol/min) 1.02 ± 0.08  
0.99 ± 0.07 
 
0.92 ± 0.04 
 
0.78 ± 0.02 
 
0.59 ± 0.05 
 
0.27 ± 0.01 
 
0.13 ± 0.0 
 
Km (mM) 23.2 ± 5.7  
21.7 ± 4.9 
 
21.3 ± 3.5 
 
19.7 ± 2.1 
 
15.8 ± 5.1 
 
12.6 ± 1.6 
 
10.2 ± 1.0 
 
[Arsenate] 0 mM 0.5 mM 1 mM 2 mM 4 mM 8 mM 12 mM 
Vmax (mol/min) 1.16 ± 0.06  
1.15 ± 0.06 
 
1.15 ± 0.07 
 
1.15 ± 0.07 
 
0.93 ± 0.09 
 
0.77 ± 0.05 
 
0.66 ± 0.04 
 
Km (mM) 31.4 ± 5.2  
32.6 ± 5.2 
 
30.6 ± 5.6 
 
30.3 ± 5.5 
 
21.3 ± 6.4 
 
15.6 ± 3.8 
 
14.9 ± 2.9 
 
Table 2.1:  Vmax and Km values of O2 reduced by laccase monitored by following 
the absorbance of ABTS in citrate-phosphate buffer, the data are obtained with 





Table 2.2: R2 values for the nonlinear regression fitting of laccase activity 


















[Arsenite] 0 0.5 1 2 4 8 12 
R2 0.9317 0.9635 0.9635 0.9499 0.8358 0.2593 0.9557 
[Arsenate] 0 0.5 1 2 4 8 12 







Inhibition model Arsenite Arsenate 
Mixed inhibition 0.8424 0.8065 
Uncompetitive inhibition 0.8310 0.8029 
Noncompetitive inhibition 0.8423 0.8060 
Competitive inhibition 0.8187 0.7757 
Table 2.3: Global R2 values retrieved from Michealis-Menten nonlinear 
regression fits for laccase under differing inhibition models for arsenite or 
arsenate. 
 Reproduced with permission from Electroanalysis 24, (2015): 854–859. Copyright 2015, John 






A PAPER-BASED MITOCHONDRIAL ELECTROCHEMICAL 
BIOSENSOR FOR PESTICIDE DETECTION 
 
In this chapter, we detail a paper-based three-electrode electrochemical 
biosensor using a mitochondria modified Toray carbon paper working electrode. 
Cyclic voltammetry performed on the paper-based biosensor and similar 
electrodes in a common laboratory setup (not in an integrated paper-based 
device) compare favorably. In addition, instant detection of malathion with a 
detection limit of 20 nM by cyclic voltammetry is demonstrated, showing the 
device can potentially be used as a portable platform for pesticides detection. 
 
3.1 Introduction 
The increasing use of pesticides rises a significant environmental problem, 
and is threatening human health via acute poisoning and long-term carcinogenic 
effects. [1] Pesticide detection plays an important role in mitigating the negative 
consequences of pesticide contamination. Many different pesticide detection 
techniques have previously been developed, with chromatographic techniques 




outstanding sensitivity (usually at the ng/ ml concentration level), they require 
expensive, bulky instrumentation not readily available in many parts of the world. 
An inexpensive, small, portable pesticide detection system would therefore be 
very useful in preventing harmful pesticide effects. 
Up till now, many low cost and disposable enzymatic or microbial paper-
based sensors have been reported utilizing different detection methods such as 
optical methods, [3] colorimetric methods [4] and electrochemical methods. [5] 
Recently, electrochemical sensors have been extensively studied because of 
their great potential as a portable sensor.  
Electrochemical sensors have a rapid response time and can be operated 
using compact ubiquitous devices such as smart phones. [6] Many enzymatic 
electrochemical pesticide biosensors have been studied including those using 
the enzymes alkaline phosphatase, [7] acetylcholinesterase (AchE), [8] glucose 
oxidase9 and organophosphate hydrolase. [10] These enzymatic biosensors 
either act via enzymatic inhibition or directly use organophosphate pesticides as 
a substrate, and they have shown good sensitivity and low detection limits. Some 
of those electrochemical sensors utilized a microfluidic or portable platform. 
Different platforms have been used for electrochemical detection, and 
among those different platforms paper-based devices stand out because of their 
ultra-low materials cost. In addition, paper utilizes capillary flow to move fluid 
samples so external pumping is not required, which further decreases device 
cost and complexity. These advantages, combined with the fact that paper-based 




for large-scale production.  
For organophosphate pesticide detection, AchE is extensively studied [11] 
and shows an outstanding low detection limit to many different organophosphate 
pesticides such as malathion (detection limit 100 nM), [12] parathion (detection 
limit 130 pM) [13] and paraoxon (detection limit 1 nM). [14] However, as a 
universal pesticide sensor, AchE is only capable of detecting neurotoxic 
pesticides, primarily organophosphate and carbamate pesticides, which are 
inhibitors of cholinesterase enzymes. Other pesticides function on completely 
different mechanisms, for instance, by blocking sodium channels, inhibiting 
cytochrome oxidase or interfering with DNA/RNA synthesis. [15] Therefore, in 
terms of universality, using an organelle or even a whole cell has a clear 
advantage over a single-enzyme assay, because they are generically sensitive to 
all toxic pesticides. As organelles, thylakoids and mitochondria have been tested 
against different pesticides via electrochemical methods and showed capability of 
detecting those pesticides at concentrations below an environmentally safe level. 
[5]  
Mitochondria are the organelles responsible for respiration and ATP 
synthesis. As shown in Figure 3.1, a previous study showed that the 
mitochondrial electron transport chain (ETC) contains electrochemical active 
species, like quinones, that are able to communicate with carbon electrodes, 
therefore allowing electrochemical monitoring of mitochondrial health. [16] For 
most pesticides, mitochondria are their primary or secondary target. [15] In 




pesticides like atrazine, parathion, paraquat and permethrin. [5a] It is notable that 
a mitochondrial biosensor can detect not only neurotoxins, but also many non-
neurotoxic pesticides, unlike an AchE based biosensor, therefore making it ideal 
for detecting a variety of pesticides. Since mitochondria produce a different 
electrochemical output in response to different toxins, it may be possible to 
distinguish between toxins using a single sensor. 
In this work, we demonstrate that a mitochondrial biosensor can be 
utilized in a paper-based platform. Malathion was used as a test case for 
evaluating the biosensor sensitivity and detection limit. The results are 
comparable to a typical enzymatic malathion sensor, which illustrates the paper-
based mitochondrial biosensor’s potential as a portable pesticide sensor. [12]  
 
3.2. Experimental  
3.2.1 Isolation of mitochondria from bovine heart 
Mitochondria were isolated from fresh bovine heart based using a slightly 
modified procedure from Rogers et al. [17] The bovine heart were cut into 3 cm 
cubes and disrupted with a blender in MHSE buffer (70 mM sucrose, 210 mM 
mannitol, 5 mM HEPES, 1 mM EGTA, 0.5 % (w/v) BSA, pH 7.2), followed by 
adjusting the pH back to near neutral, and isolating mitochondria via gradient 
centrifugation. In this process, the disrupted meat was first centrifuged at 26,000 
g for 10 min, then the pellet was resuspended and centrifuged at 500 g for 10 
min and repeated again. This process was followed by filtering the mitochondria 
pellet with cheese cloth, then centrifuging at 10000 g for 10 min twice and finally 




3.2.2 Assembling of the paper-based mitochondrial biosensor 
Toray carbon paper (TGP-H-060, FuelCell Earth, non-wet-proof) was 
chosen as the electrode material for the working and counter electrodes due to 
its large surface area. The Toray carbon paper electrodes were laser cut to a 
designated shape shown in Figure 3.2. 
The circular regions on the working and counter electrodes measured 3 
mm and 5 mm in diameter, respectively. These areas were modified with 
mitochondria and platinum as described below to become the electrochemically 
active electrode surfaces while the remaining electrodes’ surfaces were used for 
fluid and electrical conduction. The paper-based sample strip was created by 
using vinyl tape to mask a circular region on a piece of Whatman filter paper and 
then manually coating the unmasked areas with wax. The wax was melted on a 
hot plate and the mask was removed. A laser-cut polyester envelope with a 
circular hole in it for pipetting the sample was fabricated and used to contain the 
sensor components and thus increase the robustness of this device. 
 
3.2.3 Electrode modification and electrochemistry test 
Aliquots containing 7 mg of mitochondria in trehalose solution were drop 
cast on the Toray carbon paper working electrode and dried in air at room 
temperature. A thin layer of silica was vapor deposited onto the mitochondria 
using tetramethyl orthosilicate (TMOS) as previously described. [19] Platinum 
was electrochemically deposited on the Toray paper counter electrode using a 




1.8 mM KH2PO4, 1 mM CaCl2, 0.5 mM MgCl2), and cycling from 200 to -700 mV 
(vs. Ag/AgCl) at a scan rate of 50 mV/s for 25 cycles. The reference electrode 
was fabricated by curing silver epoxy on a piece of filter paper. After curing, the 
filter paper was cut into 2 mm wide strips and oxidized in 3 M FeCl3 solution for 1 
minute to generate a AgCl layer on the surface of the silver epoxy. Then, an agar 
layer with 3.5 M KCl was deposited on the surface of the electrode as a salt 
bridge. [20] Unless otherwise noted, electrochemical experiments were carried 
out by cyclic voltammetry with a potential range from 600 to -600 mV vs. Ag/AgCl 
at a scan rate of 20 mV/s, in 100 mM pH 7.2 phosphate-nitrate buffer containing 
1 mM EGTA and 5% BSA. 
 
3.3 Results and discussion 
3.3.1 Mitochondrial biosensor cyclic voltammetry in vitro  
and on the paper-based chip 
Mitochondria are considered the powerhouse of the living cell, because 
they contain a variety of metabolic pathways, including the Krebs cycle and the 
ETC. Mitochondria can communicate with an electrode via the electrochemically 
active species inside its ETC. One of the electrochemically active species in the 
ETC that is accessible through the membrane is quinone, which is believed to be 
the means of mitochondrial communication with the electrode. This was 
previously verified in our group by testing mitochondria from various biologically 
sources on Toray paper with their quinone pool depleted. This led to total 
removal of all mitochondrial peaks, revealing that quinone is the most probable 




Figure 3.3 shows the cyclic voltammogram of a bovine heart mitochondria 
modified electrode in 100 mM pyruvate in phosphate-nitrate buffer. The 
mitochondrial voltammogram shows an oxidation peak around 100 mV vs. 
Ag/AgCl and a reduction peak around -300 mV. The same peaks are also 
observed in the mitochondrial voltammogram on the paper-based chip, 
suggesting that the chip platform has a very similar electrochemical response in 
a portable platform. The small reduction peak at 0 V is commonly observed on 
Toray paper and is more noticeable on the blue curve due to the increased 
electrode size. It is noticeable that with smaller electrodes, mitochondria on the 
paper-based chip showed a smaller peak current, which is likely because of the 
different mitochondria loading density. Another difference between the 
mitochondrial electrodes on the paper-based chip and the common 3-electrode 
lab setup is that the potential difference between the oxidation peak and 
reduction peak is smaller on the paper-based chip. This can be explained by the 
higher mitochondrial loading density on the paper-based electrode, which leads 
to a lower diffusion coefficient. 
 
3.3.2 Mitochondrial inhibition by pesticides 
Many pesticides, such as parathion, permethrin and paraquat, target 
mitochondria and inhibit the different complexes in the mitochondrial ETC. [5a] 
Previously, mitochondria inhibition has been most commonly observed by 
measuring its oxygen consumption rate with the addition of different kinds of 




Mitochondrial electrochemistry is a direct method to monitor mitochondrial health, 
and it is potentially more efficient than measuring oxygen consumption, because 
tests can be performed directly in ambient air. 
When mitochondria are exposed to different toxins, different complexes 
inside the mitochondrial ETC are inhibited, e.g. permethrin inhibits complex I, [22] 
carboxin inhibits complex II, [23] cyanide inhibits complex IV [24] and malathion 
inhibits complex II and IV. [21] Previous work in our group showed that 
mitochondrial electrodes behave differently when they are exposed to different 
environmental toxins. [5a] Because of the structure of the ETC and since the 
different complexes inside the mitochondrial ETC play different roles in quinone 
redox chemistry, inhibition of different complexes inside the mitochondrial ETC 
will lead to different types of electrochemical responses. For instance, the 
inhibition of complex I would theoretically lead to a decrease of the mitochondrial 
oxidative peak and an increase of the mitochondrial reductive peak, while 
inhibition of complex III would lead to removal of all mitochondrial peaks due to 
the complete shutting down of mitochondrial ETC. In addition, for healthy 
mitochondria, the response often consists of two parts: the uncoupling effect and 
inhibition of mitochondrial complexes in the ETC. 
Uncoupling begins when mitochondria are isolated from cells. During the 
uncoupling process, the mitochondrial membrane’s permeability increases 
leading to a loss of the proton gradient between mitochondrial intermembrane 
space and matrix. [25] Therefore, the activity of mitochondrial ETC complexes 




mitochondrial membrane permeability and the increase of mitochondrial ETC 
metabolic level induces an increase of mitochondrial oxidation and reduction 
currents. [26] From Figure 3.4b, it can be seen that when mitochondria are 
uncoupled, both the oxidative peak and the reductive peak current, as well as the 
capacitance increase significantly. It can be also seen that when mitochondria 
are exposed to malathion, as shown in Figure 3.4a, the type of response is 
similar to uncoupling, while different to examples where mitochondria are 
exposed to complex II or V inhibitors, where a decrease of signal is observed. 
It was reported previously that malathion is an inhibitor for mitochondrial 
complex II and IV, as well as a mitochondrial uncoupler. [27] The increase of 
both the oxidation and reduction peaks is likely caused by mitochondrial 
uncoupling rather than ETC inhibition, which would manifest itself by increasing 
either the oxidation or reduction peak, but not both. Therefore, while uncoupling 
and ETC inhibition may both be occurring, for malathion, the uncoupling effect 
dominates the electrochemical response. Mitochondrial uncoupling happens after 
mitochondria are isolated from cells regardless of their exposure to toxins. To 
exclude the effect of time-dependent mitochondrial uncoupling, a control group 
used a mitochondrial-modified electrode similar to the one used for the 
experimental group, instead of blank carbon paper. 
Cyclic voltammetry was performed on the paper-based sensor at 
increasing malathion concentrations and in the absence of and presence of 100 
mM pyruvate (as shown in Figure 3.1). With the addition of malathion, the 




Figure 3.5 shows the mitochondrial oxidative peak current change when 
exposed to different concentrations of malathion and the mitochondrial oxidative 
peak change over time without malathion. There was no noticeable mitochondria 
uncoupling when electrodes are stored in cold environments. It can therefore be 
concluded that oxidative peak current changes are due to malathion exposure. 
Although this mitochondrial biosensor showed concentration dependency with 
malathion, this sensor was originally design as an on-off threshold sensor with a 
20 nM limit of detection at the 98% confidence level. 
 
3.4 Conclusions 
In this paper, we successfully miniaturized mitochondrial electrochemistry 
for use on a paper-based chip that was simple to fabricate and easy to use. The 
paper-based labon-a-chip device was capable of detecting malathion above 
concentrations of 20 nM. Due to its limit of detection and ease of use, this device 
shows promise as a portable sensor. Given mitochondrial sensitivity to a variety 
of pesticides and the potential ability to distinguish them, similar paper-based 
mitochondrial biosensors could be used as versatile electrochemical testing 
platforms for other pesticides as well. 
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Figure 3.1: Schematic demonstration of the bioelectrocatalysis at a 
mitochondria modified electrode and cyclic voltammetry of mitochondria 
modified electrode tested in pyruvate solution (black line) and pyruvate 











Figure 3.2: Schematic of a mitochondria three‐electrode paper‐based 
biosensor front view (above) and back view (below), showing (a) working 
electrode, (b) counter electrode, (c) Ag/AgCl reference electrode and (d) filter 















Figure 3.3: Representative cyclic voltammograms of mitochondria modified 
Toray paper electrodes in a standard three electrode system in solution (blue 
line) at 50 mV/s and representative cyclic voltammogram of bare (black line) 
or mitochondria modified (red line) electrodes in a paper‐based device at 50 
mV/s. Tests were performed in 100 mM phosphate‐nitrate buffer containing 



















Figure 3.4: (a) Cyclic voltammogram of mitochondrial electrodes in 100 
mM pyruvate solution (black) and 100 mM pyruvate solution containing 
100 nM malathion (red) and (b) Cyclic voltammogram of healthy 
mitochondrial electrodes (black) and uncoupled mitochondrial electrode 
(red) in pyruvate solution. Scan rate: 10 mV/s, nitrogen purged, in a 






Figure 3.5: (a) Mitochondrial oxidative peak current change when exposed 
to different concentration of malathion, and (b) Mitochondrial oxidative peak 
current change over 6 hours. 
 Reprinted with permission from Journal of The Electrochemical Society 163.13 (2016): H1047-






EFFECT OF RIBOFLAVIN METABOLITES ON 
MITOCHONDRIAL ELECTROCHEMISTRY 
 
Mitochondrial deficiency is the cause of many diseases and the 
determination of changes in metabolic rates usually requires lysing of the 
mitochondria and isolating individual mitochondrial proteins. Alternatively, 
mitochondria can be immobilized on electrode surfaces to utilize electroanalytical 
evaluation of metabolic rates of intact mitochondria. However, the redox 
mechanisms are still poorly understood. In this chapter, the riboflavin cycle of 
mitochondria is studied electrochemically and its impact on mitochondrial 
voltammetry is discussed. The inhibition mechanism of mitochondria by three 
different inhibitors (rotenone, carboxin, and permethrin) is discussed and it is 
found that the inhibition behavior observed electrochemically is due to not only 
ubiquinone, which is the electrochemical communicating species of mitochondrial 
electrochemistry. It is also shown that riboflavin derivatives interact with 
ubiquinone leading to a change in the intensity of ubiquinone voltammetry peaks. 
This interaction is affected by altering the choice of solvent used during the 




voltammetry of mitochondrial inhibition is due to a change in riboflavin 
metabolism within the intact mitochondria immobilized on carbon electrodes. 
 
4.1 Introduction 
Mitochondria are the primary source of respiration and ATP synthesis for 
all eukaryotic cells. The mitochondrial electron transport chain (ETC), which is 
responsible for mitochondrial respiration, contains four proteins (three for fungal 
mitochondria) and ATP synthase as well as multiple electrochemically active 
species such as ubiquinone and cytochrome c. Mitochondria contain the proteins 
of the Krebs cycle1-3 that are capable of metabolizing sugar metabolites, fatty 
acids4 and amino acids5 and have therefore been considered as attractive 
catalysts for bioelectrocatalysis applications such as biofuel cells, due to their 
high volumetric catalytic activity. The metabolism integrity and complexity also 
allows mitochondria to be responsive to many different toxins, such as inhibitors 
(rotenone, carboxin, etc.), uncouplers (dinitrophenol, dicumarol) and other toxins 
(cyanide, azide, CO), with different electrochemical responses toward different 
toxins.6-7 Since mitochondrial ETC deficiency has been recognized as the reason 
for many diseases and disorders, like early age hypertonia, Kearns-Sayre 
syndrome, Alzheimer’s and Leber’s hereditary optic neuropathy,8 an 
electrochemical biosensor  incorporating mitochondria could possibly be an 
alternative biosensor technology to the current mitochondria deficient study that 
is based on mouse models. 




terms of practical application, mitochondrial fuel cells with advantageous fuel 
adaptation, power output and complete biofuel oxidation as well as mitochondrial 
biosensors with universality have been reported.6-7,9-14Mitochondria contain many 
different electrochemically active species, like flavin adenine dinucleotide (FAD),4 
riboflavin mononucleotide (FMN), ubiquinone,15 and cytochrome c4 which lead to 
discussions of mitochondrial electrochemical mechanisms, when mitochondria 
are immobilized at electrode surfaces. Li et al. suggest that mitochondrial 
electrochemistry is a function of FAD and cytochrome c separately. Using 
mitochondria from the liver of guinea pig in their publication, they declared that 
the electrochemistry of whole mitochondria has no difference compared to 
submitochondrial particles and the electrochemical species were determined by 
comparing mitochondrial redox potentials to the redox potential of FAD and 
cytochrome c individually.4 Minteer et al. suggest that ubiquinone is the key 
species for mitochondria electrochemistry where research was based on the 
individual depletion of ubiquinone and cytochrome c to determine which species 
contributed to the resulting electrochemical response.15-16 All of these 
electrochemical measurements have been done on carbon electrode surfaces, 
because there is good adhesion of the mitochondria to the carbon electrode 
surfaces compared to gold, ITO, etc.  
Mitochondria are complex organelles that contain many electrochemically 
active species which may be involved in the electrochemical mechanism;17 
however, those redox active species were rarely included in previous discussions 




studied electrochemically in many different cases,6-7 with limited discussion of the 
effect of those redox active species on the electrochemical inhibitory response. 
However, different from a typical enzymatic system where only a single enzyme 
or an enzyme cascade where all the components are known, mitochondria 
contain more than just the ETC, which is responsible for respiration, but also 
enzymes for the whole Krebs cycle as well as enzymes for vitamin metabolism 
and even enzymes for its own genetic system. Those biological systems consist 
of redox active substrates, products, cofactors, and enzymes that might also 
contribute toward mitochondrial electrochemistry. Among those electrochemical 
species, FMN/FAD are small, water-soluble redox active molecules that exist 
both in the mitochondrial matrix and the intermembrane space and are able to 
diffuse through the mitochondrial outer membrane, therefore making it possible 
for them to play a role in mitochondrial electrochemistry. 
Therefore, as shown in Figure 4.1, we hypothesized that the 
electrochemistry of mitochondria on Toray paper electrodes are due to a 
contribution from both FMN/FAD and ubiquinone. In this paper, the interaction 
between FMN/FAD and ubiquinone is studied via dropcasting their mixture 
directly onto Toray paper electrodes and it is found that their interaction differs in 
aprotic and protic environments. One more portion of mitochondrial metabolism, 
the riboflavin/FAD cycle, is taken into consideration in order to explain the 
electrochemical behavior of mitochondria. An increase in the exportation of 
mitochondrial FMN/FAD is observed when mitochondria are inhibited. In 




likely due to the exportation of FMN/FAD and the change of interaction between 
FMN/FAD and ubiquinone. 
 
4.2 Experimental 
4.2.1 Chemicals and materials 
Fresh bovine heart was purchased from a local slaughter house (Dale T 
Smith&Sons, Draper, UT, USA) and soaked in MHSE buffer (70 mM sucrose, 
210 mM mannitol, 5 mM HEPES, 1 mM EGTA, 0.5% (w/v) bovine serum albumin 
(BSA), pH 7.2) as well as kept on ice during the transportation process. 
Untreated Toray paper was purchased from Fuel Cell Earth (USA) and cut into 1 
cm2 squares and used without further treatment. All the other chemicals were 
purchased from Sigma-Aldrich (USA) and used as received. 
 
4.2.2 Isolation of bovine heart mitochondria 
Mitochondria were isolated from bovine heart based on a modified 
procedure from Rogers et al.18 During the isolation, the bovine heart muscle was 
cut into 2 cm × 2 cm cubes and blended in a laboratory blender. Then the tissue 
was centrifuged at 26000x g for 10 min and the pellet was collected. Afterwards, 
the pellet was resuspended and centrifuged at 500x g twice and the supernatant 
was collected. Then the suspension was centrifuged at 10000x g twice, and the 
mitochondria were finally stored in 300 mM trehalose buffer (T buffer, 300 mM 
trehalose, 1 mM EDTA, 1 mM EGTA, 5 mM HEPES, 0.1% (w/v) BSA, 1% (w/v) 




the Seahorse oxygen consumption assay to insure the isolated and purified 
mitochondria are intact and functional before use on an electrode. 
 
4.2.3 Mitochondrial toxicity test 
Mitochondrial suspension (200 mg mL−1) was mixed individually with 
rotenone, permethrin or carboxin. The toxins were mixed with mitochondrial 
suspension individually at saturation (1 mg per 500 μL mitochondrial suspension) 
and the mixtures were vortexed for 30 min. The suspensions were cast on 1 cm2 
Toray paper electrodes immediately following the sonication process to prevent 
the precipitation of insolubilized toxin. The electrodes are then dried in a hood for 
approximately 30 min and then treated with TMOS vapor deposition, as 
described before,15 in order to permanently immobilize the mitochondria on the 
electrode. To eliminate possible activity variation between different batches of 
isolated mitochondria, only the mitochondria from one batch of isolation were 
used in the test of one kind of toxins. Electrochemical evaluation was carried out 
in a standard 3-electrode electrochemical cell via cyclic voltammetry (CV) 
between −0.6 to 0.6 V (vs. Ag/AgCl (sat.)) for 2 cycles in nitrogen-purged 200 
mM phosphate-nitrate buffer containing 0.5% (w/v) BSA. Pt mesh was used as 
the counter electrode. All negative currents correspond to oxidation currents. 
 
4.2.4 Riboflavin derivatives electrochemical evaluation 
FAD, FMN and ubiquinone were solubilized individually in water or ethanol 




electrodes. Extra solvent was used during mixing to maintain a constant ratio of 
total solvent (water/ethanol). Electrochemical evaluation was carried out via 
cyclic voltammetry as described above. 
 
4.2.5 Riboflavin assay 
The export of riboflavin derivatives from mitochondria was monitored by 
UV-Vis on a Thermo-Fisher Nanodrop 2000. The mitochondrial suspensions (500 
μL of 200 mg/mL) were first incubated with different inhibitors at room 
temperature for 30 min, lyophilized overnight, then resuspended in 50 μl T buffer 
and centrifuged at 10000x g for 10 min. The FAD/FMN content in the supernatant 
were measured by UV absorption at 390 nm. 
 
4.2.6 Mitochondria lysate 
Mitochondria were lysed by using surfactants and sonication, as per a 
standard literature procedure.20 A Triton-X100 solution was mixed with the 
mitochondrial suspension at a ratio of 1:100 ml/mg protein, vortexed for 20 min 
and then sonicated with a Fisher-Scientific FB 505 sonicator for 2 min (4 cycles 
of sonication of 30 seconds and resting on ice for 1 min). The lysate were directly 
drop-cast on Toray paper electrode, prepared and tested following the same 





4.3 Results and discussion 
4.3.1 Electrochemical characterization of mitochondria inhibition  
The black lines in Figure 4.2 represent typical mitochondrial 
electrochemical behavior when immobilized on Toray carbon paper electrodes 
where a reduction peak at approximately −0.3 V (vs. Ag/AgCl) and an oxidation 
peak at approximately 0.15 V (vs. Ag/AgCl) are present that are due to 
ubiquinone.15 Known Complex I inhibitors permethrin and rotenone21-23 were 
tested on mitochondrial electrodes, while permethrin also interrupts mitochondrial 
sodium channels. None of those inhibitors are electrochemically active in the 
potential window of the experiment (Blue line, Figures 4.2A, 2B and 2C).24 
However, although both of those inhibitors affect ubiquinone reduction of 
complex I, their electrochemical behaviors are marginally different. As shown in 
Figure 4.2A, the inhibition of Complex I by permethrin resulted in an enhanced 
reduction wave and a diminished oxidation wave in cyclic voltammetry which is a 
function of the mitochondrial bioelectrocatalytic response toward the inhibition of 
ubiquinone reduction. Meanwhile with rotenone (as shown in Figure 4.2B), the 
mitochondrial oxidation and reduction wave were both diminished. It is shown in 
Figure 4.2 that although ubiquinone has been long reported as the key species in 
mitochondrial electrochemistry,15 it may not be the only electrochemically active 
species involved in mitochondrial electrochemistry. To further study the inhibition 
behavior of mitochondria, a Complex II inhibitor (carboxin) was employed. 
Carboxin is a non-electrochemically active (Figure 4.2C) Complex II inhibitor25-26 




shown in Figure 4.2C, the loss of the ubiquinone reduction activity leads to a 
decrease of the peak height on both the reduction and oxidation peaks, similar to 
what was observed by rotenone-inhibited mitochondria (Figure 4.3). Therefore, it 
is hypothesized that ubiquinone is not the sole electrochemically active species 
involved in mitochondrial electrochemistry. 
In previous studies, many different electrochemically active species in 
mitochondria have been tested (such as cytochrome c, ubiquinone, FAD and 
FMN). Based on the potential observed via mitochondrial cyclic voltammetry, it is 
unlikely that any other electrochemical species other than ubiquinone is the 
actual species involved in mitochondrial electrochemistry, because of the 
observed differences in redox potentials.27-29 Meanwhile, this electrochemical 
behavior does not follow a typical prediction of electrocatalytic behavior following 
inhibition, indicating that although ubiquinone appears to be the predominant 
species of mitochondrial electrochemistry, there may be other electrochemically 
active species in mitochondria that are involved in mitochondrial 
electrochemistry. 
Based on the fact that in the potential range of 0.6 to −0.6 V (vs. Ag/AgCl), 
none of the possible electrochemically active species (other than ubiquinone) 
present significant peaks in mitochondrial electrochemistry, indicating that 
mitochondrial inhibition electrochemistry is most likely due to a possible 
interaction between mitochondrial redox active species. One of the possible 
interactions between two mitochondrial electrochemically active species 




in a hydrophobic environment such as in a mitochondrial lipid membrane.17 
However, in this case, the interaction between NAD+/NADH and ubiquinone 
during which ubiquinone acts as an electron mediator for the oxidation of NADH 
still follows a different pattern as observed during mitochondrial inhibition. 
Another possible interaction, which is rarely reported, is between 
FMN/FAD and ubiquinone. FMN and FAD are cofactors of mitochondrial 
Complexes I and II as well as products/substrates of the mitochondrial riboflavin 
metabolism cycle. Moreover, FAD is also involved in the mitochondrial 
glycerophosphate shuttle. Considering all of these metabolic pathways 
combined, FMN and FAD appear in both mitochondrial matrices and the inter-
membrane space. As reported, hydrophilic NAD+/NADH could be chemically 
mediated via hydrophobic ubiquinone located in the lipid membrane;17 therefore, 
it is hypothesized that FMN/FAD might interact with ubiquinone in a similar 
fashion. 
To mimic the electrochemical conditions of the mitochondrial inhibition 
electrochemical analyses, Toray carbon paper was chosen as the electrode 
material and FMN/FAD, ubiquinone, and their mixtures were drop-cast on the 
electrode. Cyclic voltammetry of both FMN and FAD result in a single pair of 
redox peaks at approximately −0.4 V (vs. Ag/AgCl) (Figure 4.4) on Toray paper. 
As shown in Figure 4.5A, with the mixture of FMN and ubiquinone dissolved in 
ethanol and cast on a Toray paper electrode (while the ratio of FMN increases 
although the total amount of solvent remains the same), the ubiquinone oxidation 




37% and 409 ± 69% as the ratio of FMN:ubiquinone increases from 0:1 to 1:1, 
2:1 and 4:1. Additionally, FAD behaved in a similar fashion to FMN when mixed 
with ubiquinone (Figure 4.6). In this case, ubiquinone acts as an electron 
mediator for FMN. However, this redox pathway changes when water is present 
during the drop-casting process, as shown in Figure 4.5B. In this case, the 
oxidation peak current of ubiquinone decreases by 167 ± 4%, 272 ± 12% and 
1489 ± 3% with the ratio of FMN:ubiquinone increase from 0:1 to 1:1, 2:1, and 
4:1. 
It is hypothesized that the observed mitochondrial electrochemistry could 
be a result of the interaction of FMN/FAD and ubiquinone. To demonstrate that 
such a system is being observed during mitochondrial electrochemistry (i.e. 
FAD/FMN enhance/decrease the electrochemical signal of ubiquinone with 
negligible electrochemical signal of itself appearing), a mixture of FAD, FMN and 
ubiquinone with a ratio of FAD:FMN:ubiquinone of 1:1:100 was drop-cast on 
Toray paper electrode for 14 hr while all the chemicals are dissolved in ethanol 
(Figure 4.7). It can be seen that FAD and FMN diffuse away from the electrode 
during evaluation; however, the enhancement of quinone redox peaks decreases 
by 17 ± 8% which is on a much smaller scale compared to the redox peaks 
associated with FMN/FAD which decreased by 95 ± 2%, indicating that this 
process is dominantly surface bound.30  
To demonstrate that the hydrophobic environment created via the lipid 
membrane will result in a similar phenomenon, ubiquinone was dispersed in the 




electrode. In this test, the ubiquinone oxidation peak increases at 115 ± 27%, 
123 ± 14% and 810 ± 7% with the ratio of FMN:ubiquinone increase from 0:1 to 
1:1, 2:1 and 4:1, with the existence of lipid membrane, even though FMN and 
ubiquinone were mixed in an aqueous solution. 
To further demonstrate how this change in the local environment could 
affect the electrochemical response of mitochondrial electrochemical species, 
lysate of mitochondria was prepared. From Figure 4.5C, it can be seen that after 
lysing the mitochondria, both the mitochondrial oxidative and reductive peaks 
disappear. Since lysing will disrupt the lipid membrane in mitochondria, removing 
the hydrophobic environment maintained by it, therefore the electrochemistry 
behaves like the situation in Figure 4.5B, and finally leads to decrease or 
complete removal of mitochondrial redox peaks. 
In mitochondria, riboflavin (vitamin B2) is metabolized to FMN and then 
FAD. During this process, riboflavin diffuses into the mitochondrial inter-
membrane space and is then transported into the mitochondrial matrix via a 
riboflavin transporter, where it is metabolized to FMN and FAD.31 In this process, 
four enzymes (riboflavin kinase, FAD synthetase, FAD pyrophosphatase, FMN 
phosphohydrolase) are involved as well as multiple carrier-based riboflavin 
transporting systems.32 FMN and FAD are present in both the mitochondrial 
matrix and mitochondrial inner-membrane space. However, even though this 
interaction could be altered in vitro, whether their interaction in mitochondria 





To demonstrate that the change of mitochondrial riboflavin metabolism 
could alter their electrochemical behavior, mitochondria were tested by feeding 
FMN/FAD as a substrate for riboflavin metabolism. Both FMN and FAD are 
capable of diffusing into the mitochondrial inter-membrane space; therefore, 
during testing they were directly mixed with the mitochondria and incubated at 
room temperature for 20 min. Since FAD pyrophosphatase is inhibited by EDTA 
in mitochondrial riboflavin metabolism,33 mitochondria were transferred to 
trehalose buffer in the last stage of the mitochondria isolation process, which 
kept them coupled in the flash freeze-thaw cycle.19 To prevent the inhibition of 
mitochondrial riboflavin metabolism, a portion of mitochondria were kept in their 
original buffer that contained only EGTA as a protease inhibitor. As shown in 
Figure 4.8, the addition of 10 mM FMN/FAD resulted in an increase of 
mitochondrial oxidation peak current when mitochondria were suspended only in 
MHSE buffer which contains no EDTA, while with the mitochondria suspended in 
trehalose buffer, no change is observed with the addition of FMN or FAD which 
indicates that the interaction of FMN/FAD and ubiquinone observed in vitro was 
not observed from the intake of external FMN or FAD; therefore, the interaction 
of FMN/FAD and ubiquinone is a consequence of mitochondrial riboflavin 
metabolism. 
Since the mitochondria used in the inhibition test were suspended in 
trehalose buffer, the intake of riboflavin derivatives is inhibited (the synthesis of 
FMN/FAD is not likely to happen during this process). In active mitochondria, 




Coupled mitochondria export FMN and FAD synthesized from riboflavin, FMN or 
FAD uptake, into cytosol.32,34 It has also been demonstrated that mitochondria 
with ETC deficiency result in a shortage of riboflavin and derivatives thereof.35 
For the bovine heart mitochondria used in this research, we observed that the 
concentration of FMN/FAD in the supernatant of mitochondrial suspension 
increases from 38.1 ± 11.7 μM to 53.8 ± 9.4 μM (rotenone) and 66.6 ± 3.2 μM 
(carboxin) during the inhibition process. As a result of the increase of FMN and 
FAD export due to inhibition, an increase in the portion of the interaction between 
FMN/FAD and ubiquinone occurs in a protic environment, which causes the 
decrease of mitochondrial voltammetric peaks observed. 
 
4.4 Conclusion 
In this chapter, we report the voltammetric observation of mitochondrial 
inhibition via three different inhibitors (rotenone, permethrin and carboxin), which 
indicates that mitochondrial electrochemistry is not solely a function of 
ubiquinone mediation. Instead, it is shown that the intensity change of 
mitochondrial voltammetric peaks could reflect a change of mitochondrial 
metabolism related to its riboflavin cycle. Such a change of mitochondrial 
voltammetry during inhibition is a result of a change in the interaction of 
FMN/FAD and ubiquinone, which changes its mechanism in different chemical 
microenvironments. The understanding of such a mechanism shows that 
electrochemical methods can be used for assessment of mitochondrial 




therefore, avoiding the protein isolation process. Due to the additional 
mechanistic information, this method provides more information than just 
deficiency of the mitochondrial ETC. Also the surface interaction between 
ubiquinone and riboflavin derivatives provide a new path for enhancing the power 
output of mitochondrial biofuel cell or self-powered biosensors utilizing quinone 
or riboflavin derivatives as their electron mediators. 
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Figure 4.1: Mitochondrial riboflavin cycle in normal state (small figure, (A)) 




























Figure 4.2: Representative cyclic voltammograms of mitochondria-modified 
Toray paper electrodes in 200 mM phosphate-nitrate buffer in the absence ((A), 
(B) and (C), black line) or presence of permethrin ((A), red line), rotenone ((B), 
red line) and carboxin ((C), red line), as well as permethrin ((A), blue line), 
rotenone ((B), blue line) and carboxin ((C), blue line) modified electrode. All 
experiments were performed at 10 mV/s with nitrogen purging to eliminate 










Figure 4.3: Background-subtracted oxidative peak current of 
mitochondria with (red bar) or without (black bar) the presence of 
rotenone (A) and carboxin (B). All tests were performed in 200 mM 
phosphate-nitrate buffer (pH 7.2, containing 0.5 % BSA) with nitrogen 












Figure 4.4: Representative cyclic voltammetry of FMN (A) and FAD (B) drop-
cast on 1 cm2 Toray paper electrode in 100 mM phosphate-nitrate buffer (pH 























Figure 4.5: Representative cyclic voltammograms of FMN and ubiquinone 
mixture cast on Toray paper with different ratio of ubiquinone and FMN with 
(A) ubiquinone and FMN both dissolved in ethanol and (B) ubiquinone 
dissolved in ethanol and FMN dissolved in water. Figure (A) and (B) insets: 
enlargement of the ubiquinone oxidation peak in the corresponding figures. 
(C) Representative cyclic voltammetry of intact (black line) and lysed 
mitochondria (red line) in 200 mM phosphate-nitrate buffer with nitrogen 


















Figure 4.6: Representative cyclic voltammetry of ubiquinone-FMN/FAD 
mixture in 200 mM phosphate-nitrate buffer with the ratio of ubiquinone: FAD 

















Figure 4.7: Representative cyclic voltammetry of FMN, FAD and ubiquinone 
mixture monitored over time, recorded at beginning (black line), 20 min (blue 
line), 40 min (pink line), 240 min (navy line) and 840 min (purple line). All 














Figure 4.8: Representative cyclic voltammetry of intact (black line) and 
lysed mitochondria (red line) in 200 mM phosphate-nitrate buffer with 
nitrogen purging. All tests were performed at 10 mV/s. 
Figure 4.8: (A) and (B) cyclic voltammetry of mitochondria and their mixture 
with FMN and FAD with (A) mitochondria suspended in MHSE buffer and (B) 
mitochondria suspended in T buffer; (C) and (D) oxidation peak current of 
mitochondria and their mixture with FMN and FAD with (A) mitochondria 
suspended in MHSE buffer and (B) mitochondria suspended in T buffer. All 
tests were performed in 200 mM phosphate-nitrate buffer with nitrogen 








CONCLUSION AND FUTURE WORK 
 
5.1 Conclusions 
In this research, two biosensors were developed for groundwater 
monitoring, targeting two of the most commonly seen environmental pollutants - 
arsenic and pesticides (malathion). The emphasis on these projects was to 
observe the inhibition of the biotransducer, laccase or mitochondria, by 
environmental toxins and analyze the inhibition mechanisms. 
In Chapter 2, the monitoring of arsenic (specifically, arsenite and arsenate) 
is performed via a laccase-modified biocathode. In this project, laccase is 
immobilized on anthracene-modified multilwalled carbon nanotubes. The purpose 
of anthracene-modified multiwalled carbon nanotubes is to orientate the T1 copper 
center of laccase towards the surface of the electrode due to the structural 
similarity of anthracene to the natural phenolic substrates of laccase. With the T1 
copper site exposed and orientated towards the electrode, direct electron transfer 
was achieved for oxygen reduction catalyzed by laccase. The catalytic current of 
oxygen reduction catalyzed by laccase was observed to be decreased by the 
presence of arsenite and arsenate due to their inhibition effect on laccase. It was 




from the system (usually achieved by moving the laccase-modified electrode into 
a clean buffer solution); therefore, the inhibition of laccase by arsenite and 
arsenate was determined to be reversible. 
The inhibition mechanism of laccase by arsenite and arsenate was further 
determined by Michealis-Menten nonlinear regression and Lineweaver-Burk 
double-reciprocal plots. The laccase activity assay was performed by UV-Vis under 
the wavelength of 420 nm using ABTS as substrate. It was determined that the 
inhibition of laccase by arsenite and arsenate falls under the mixed inhibition 
category. The sensitivity of laccase modified electrodes (with the presence of 
anthracene-modified multiwalled carbon nanotubes) was determined with 
amperometry at the potential of 0.2 V (vs. SCE) and was 46.9 ± 7.0 µA/mM and 
10.6 ± 1.2 µA/mM for arsenite and arsenate, respectively. The corresponding linear 
dynamic ranges of laccase modified electrodes were approximately 0.5 – 5 mM for 
arsenite (R2 = 0.9923) and 0.5 - 8 mM for arsenate (R2 = 0.9894). 
For a preliminary study of a field deployable biosensor, a self-powered 
biosensor was fabricated with a FAD-GDH anode and laccase cathode. It was 
found that the catalytic current of the FAD-GDH bioanode (utilizing ferrocene-LPEI 
as mediator) was not affected by the presence of arsenite or arsenate. Therefore, 
for the glucose/O2 fuel cell-based self-powered biosensor, the power output of this 
fuel cell is solely affected by the cathode. With 100 mM glucose, the maximum 
power output reaches 57.2 ± 1.9 µW cm-2. The glucose/O2 fuel cell is operated at 
10% of its maximum current and the potential of the fuel cell is reduced by the 




fuel cell was found to be 13 µM and 132 µM for arsenite and arsenate, respectively, 
and the sensitivities were 0.91 ± 0.07 mV/mM and 0.98 ± 0.02 mV/mM for arsenite 
and arsenate, respectively. The device showed a linear range of 1-20 mM for 
arsenite and 1-8 mM for arsenate, making it capable of detecting acute arsenic 
poisoning. 
In Chapter 3, the isolation and characterization of mitochondria from bovine 
heart was discussed. Coupled mitochondria were isolated from bovine hearts 
obtained from a local slaughter house. Mitochondria were isolated by gradient 
centrifugation and the metabolism of mitochondria was studied by the seahorse 
oxygen consumption system. Coupled mitochondria were isolated from bovine 
heart and were tested against different environmental toxins. Mitochondria were 
transferred onto a paper-based platform. The paper-based platform was 
assembled from a filter-paper-based sample pool, Toray paper working electrode, 
Ag/AgCl reference electrode, and Pt-modified Toray paper counter electrode. The 
filter-paper based sample pool was fabricated via a wax screen-printing process.  
While the working and counter electrodes were fabricated by laser-cutting, the 
counter electrodes were further modified with platinum via electrodeposition. The 
Ag/AgCl reference electrodes were fabricated by oxidizing cured silver epoxy with 
FeCl3 and coating it with agar as a salt bridge. Transfer of mitochondria from a 
normal laboratory set-up to the microfluidic chip was performed successfully, with 
only slight increases in capacitance and resistance. 
The electrochemical behavior of isolated mitochondria was studied via 




contributed to by ubiquinone inside the mitochondrial electron transport chain. 
However, coupled mitochondria showed two combined toxicity effects, inhibition 
and uncoupling. Mitochondrial uncoupling happens during mitochondrial apoptosis 
or when mitochondria are isolated from the original cellular environment. 
Mitochondrial uncoupling increases mitochondrial inner membrane permeability 
and allows more electrochemically active species to pass the mitochondrial 
membrane, resulting in an observed increase of capacitance and redox peak 
current. However, inhibition of the mitochondrial electron transport chain usually 
induces a decrease of mitochondrial electrochemical response, i.e. redox peak 
current. After comparing the mitochondrial response with inhibitors and uncouplers, 
a conclusion was drawn that the toxicity of malathion to mitochondria is due to 
uncoupling. Another study was performed to test the stability of isolated 
mitochondria using the mitochondrial redox current as the indication of 
mitochondrial uncoupling. It was found that 6 hours later, the mitochondrial current 
has no significant difference from the initial current, demonstrating that this 
mitochondria-based biosensor is stable enough to neglect the self-uncoupling of 
mitochondria. The performance of the biosensor was further characterized and 
was determined as an on-and-off sensor with a detection limit of 20 nM, capable 
for field-deployable tasks. 
In Chapter 4, the electrochemical mechanism of mitochondria on Toray 
carbon paper electrodes was further studied. A few different mitochondrial 
inhibitors, like permethrin, rotenone, carboxin, and antimycin, were studied at a 




mitochondria to these toxins was difficult to obtain due to the low solubility of the 
toxin. Therefore, a new technique was used to observe the toxicity of these 
inhibitors with mitochondria. The inhibitors were incubated with mitochondria 
individually and co-cast with mitochondria on the electrode. A satisfactory result of 
mitochondrial inhibition induced by these inhibitors was observed and the result is 
contrary to the previous hypothesis.  
In previous studies, ubiquinone was believed to be the sole 
electrochemically active species in mitochondrial electrochemistry; therefore, a 
typical electrocatalytic response was expected for inhibited mitochondria. However, 
such behavior was only observed for permethrin, while for rotenone, carboxin, and 
antimycin, the response manifested as a decrease or elimination of the 
mitochondrial electrochemistry response, indicating that ubiquinone might not be 
the sole electrochemically active species in mitochondria. 
In this case, riboflavin derivatives were picked as a possible candidate the 
mechanism of mitochondrial electrochemistry. However, the redox potential of 
riboflavin was different from the potential observed for mitochondrial 
electrochemistry. In a further study of combined FMN and ubiquinone, it was found 
that riboflavin derivatives and ubiquinone had a synergistic effect when they are 
co-cast on Toray carbon paper electrode with ethanol as solvent. The 
electrochemical signal of ubiquinone was significantly enhanced when riboflavin 
derivatives were present (FMN, FAD). However, this effect could be easily altered 
by changing the solvent used during the drop-cast process. When water was 




electrochemical signal of riboflavin derivatives was enhanced. Such phenomena 
suggests that riboflavin derivatives act as the “switch” for the electrochemistry of 
ubiquinone inside mitochondria. 
FMN and FAD are the cofactors of the mitochondrial electron transport 
chain enzymes (FMN is the cofactor of complex I, FAD is the cofactor of complex 
II). Mitochondria possess a whole system of riboflavin derivatives. To prove that 
the level of riboflavin in mitochondria is affected by mitochondrial inhibition, a 
photometric assay was performed by UV-Vis and it was observed that the 
concentration of riboflavin in the supernatant of the mitochondria suspension 
increased by almost 100% when mitochondria were exposed to inhibitors. It 
appears that mitochondria were releasing FMN/FAD into the supernatant, thereby 
altering the mitochondrial electrochemical response. 
To further prove that mitochondrial lipid membranes offer a hydrophobic 
environment and make the synergy between the riboflavin derivatives and 
ubiquinone shift in the direction of enhancing the electrochemical response of 
ubiquinone, ubiquinone was suspended in lipid membrane and co-cast with FMN. 
It was shown that despite the existence of water in the mixture, with the presence 
of lipid membrane, the synergy of ubiquinone-FMN/FAD is still in favor of 
enhancing the electrochemical response of ubiquinone. 
Attempts at altering the mitochondrial metabolism were performed and 
EDTA was used as an inhibitor for riboflavin transport in mitochondria to further 
prove that FMN/FAD could be an indication of mitochondrial metabolism change. 




mitochondrial electrochemistry was altered by the addition of riboflavin derivatives. 
When EDTA was present, the addition of FMN/FAD had no effect on mitochondrial 
electrochemistry; however, when EDTA was removed, the addition of FMN/FAD 
increased the mitochondrial electrochemistry signal, showing that the changing of 
riboflavin metabolism has significant effect on mitochondrial electrochemistry. This 
finding improved the theory of using electrochemistry as a method for 
mitochondrial deficiency analysis. 
 
5.2 Future work 
5.2.1 Future improvements on laccase-based biosensor 
In previous studies, the highest current of laccase is obtained by using 
anthracene-modified carbon nanotube1; however, in this case, the modification of 
multiwalled carbon nanotube, either through pyrene π-π stacking or covalent 
binding, limits the contact of laccase and electrode. For an electrochemical 
biosensor, increase of the current response is directly linked to the possible 
increase of signal-noise ratio; therefore, further improvements to the current output 
of laccase biocathode would improve the performance of the biosensor. 
In previous studies in the Minteer group, redox polymer has been shown to 
provide significantly improved current over surface-modified carbon nanotubes. It 
has shown before that naphthoquinone can act in a similar role to anthracene to 
dock laccase towards the electrode.2 Although in the previous reported work, 
naphthoquinone was immobilized through pyrene π-π stacking on multiwalled 




laccase would be to immobilize laccase with naphthoquinone-modified redox 
polymers, such as naphthoquinone-LPEI.3 However, based on previous results, 
anthracene-modified multiwalled carbon nanotubes still possess higher oxygen 
reducing current than naphthoquinone-modified carbon nanotubes. Therefore, 
investigations should also be done using an anthracene-based polymer for laccase 
immobilization for an even better oxygen-reducing current. 
Another way to improve the current output of laccase biocathodes is to 
increase the oxygen concentration. For groundwater monitoring purposes, the 
laccase biocathode is operated in an aqueous environment where the 
concentration of oxygen in water is inherently limited by the solubility of oxygen in 
water. A recently published article indicates that incorporating lipids in an oxygen 
reducing system increased the oxygen reducing current of bilirubin oxidase, 
another oxygen reducing enzyme, by 2 fold.4 Therefore, it is possible that this 
would be a potential method of increasing the oxygen-reducing current of laccase 
in an aqueous solution. 
 
5.2.2 Future work on mitochondria-based biosensor 
A current issue that the mitochondrial biosensor is facing is the lack of 
specificity. Ideally, a mitochondrial biosensor would be able to distinguish different 
environmental toxins since mitochondria carries five different enzymes in its 
electron transport chain and they perform different roles in terms of ubiquinone 
redox chemistry. However, the newest findings of mitochondria electrochemistry 




ubiquinone, and that mitochondrial inhibition induces FMN/FAD loss in 
mitochondria which reduces ubiquinone electrochemical signal. This leads to a 
lack of specificity in the mitochondrial biosensor, especially between the inhibition 
of complexes I, II, and III in mitochondria as they would all have similar response: 
reducing of electrochemical signal. 
One way to increase the specificity of mitochondrial biosensors is to 
discover the electrochemical response from other electrochemically active species 
in mitochondria. Other than ubiquinone and FMN/FAD, the most probable 
electroactive species in mitochondria is cytochrome c. However, the molecular size 
of cytochrome c does not allow it to diffuse out of the mitochondrial intermembrane 
space. To make it possible to observe mitochondrial cytochrome c 
electrochemistry, a structural modification on mitochondria needs to be performed. 
Since cytochrome c is a membrane bound protein that binds to the inner 
membrane of mitochondria and is confined in the mitochondrial intermembrane 
space, an easy strategy would be to remove the mitochondrial outer membrane. 
Such sub-mitochondria particles are called mitoplasts and their successfully 
preparation has been reported.5-7 Preparation of mitoplasts mostly involves the use 
of surfactants to remove the outer membrane from mitochondria. In this case, 
quality control experiments will be vital for ensuring the intactness of mitoplasts. 
The seahorse oxygen consumption assay could be used to determine the 
functional integrity of mitoplasts with cytochrome c as one of the substrates. For 
the electrochemical characterization of mitoplasts, cytochrome c needs to be co-




transport chain such that specific detection of mitochondrial complexes III and IV 
could be achieved. 
It is notable that significant protein leaching was observed with the current 
TMOS immobilization technique, so it can be predicted that with cytochrome c and 
mitoplasts, the same issue may make the analysis of mitochondrial complexes III 
and IV inhibition problematic. To solve the protein leaching problem, a new 
immobilization method for mitochondria is needed. Cellulose is a biocompatible 
material that has been used for enzyme immobilization previously and is known to 
retain enzyme activity.8-10 Therefore, it is an ideal candidate for co-immobilizing 
mitoplasts and cytochrome c. 
The co-immobilization of cytochrome c and mitoplasts with cellulose can be 
performed in a layer-by-layer approach. Leaching of protein will need to be 
monitored with BCA protein assay. The lifespan of the mitoplast biosensor will be 
determined. A continuous test with seahorse oxygen consumption assay will be 
performed with cellulose immobilized cytochrome c and mitoplast. Finally, the 
biosensor will be tested against different mitochondrial inhibitors. It is expected that 
mitochondrial complexes III and IV inhibition could be observed via cytochrome c 
electrochemistry, while inhibition of mitochondrial complexes I, II, and III could be 
monitored via ubiquinone electrochemistry, thereby providing more specificity for 
the mitochondria-based biosensors. 
In summary, both laccase and mitochondria-based biosensors have 
demonstrated their effectiveness in groundwater monitoring. Although, because of 




application for environmental monitoring at the moment. They are strong 
candidates for large-scale applications due to their advantageous size and 
instrumentation requirements in a field-deployable scenario.  
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